Table Of Contents:

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Technology

  2.3.2 Market Size By Sample Type

  2.3.3 Market Size By Patient Type

  2.3.4 Market Size By End Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Testing technology performance & diagnostic accuracy metrics

4.1.1 Share (%) of demand by technology (serological test, lymphocytic transformation test, urine antigen testing, immunofluorescent staining, nucleic acid test).

4.1.2 Improvement (%) in diagnostic sensitivity, specificity, and early disease detection capabilities.

4.1.3 Reduction (%) in false-positive results, false-negative results, and diagnostic uncertainty.

4.2 Sample type performance & testing efficiency metrics

4.2.1 Share (%) of demand by sample type (blood, urine, CSF, other blood samples).

4.2.2 Improvement (%) in sample reliability, testing accuracy, and diagnostic turnaround time.

4.2.3 Reduction (%) in sample collection errors, processing delays, and retesting requirements.

4.3 Patient population diagnostics & clinical outcome metrics

4.3.1 Share (%) of demand by patient type (adult, pediatric).

4.3.2 Improvement (%) in early diagnosis rates, treatment initiation efficiency, and patient management outcomes.

4.3.3 Reduction (%) in disease progression, misdiagnosis rates, and long-term complications.

4.4 End-use performance & laboratory productivity metrics

4.4.1 Share (%) of demand by end use (hospitals, diagnostic laboratories, others).

4.4.2 Improvement (%) in testing capacity, workflow efficiency, and diagnostic service quality.

4.4.3 Reduction (%) in reporting delays, laboratory bottlenecks, and operational inefficiencies.

5. Lyme Disease Testing Market Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Serological Test

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Lymphocytic Transformation Test

 5.4 Urine Antigen Testing

 5.5 Immunofluorescent Staining

 5.6 Nucleic Acid Test

6. Lyme Disease Testing Market Analysis & Forecast, By Sample Type, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Blood

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Urine

 6.4 CSF

 6.5 Other Blood Samples

7. Lyme Disease Testing Market Analysis & Forecast, By Patient Type, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Adult

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Pediatric

8. Lyme Disease Testing Market Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Diagnostic Laboratories

 8.4 Others

9. Lyme Disease Testing Market Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Lyme Disease Testing Market Size & Forecast, By Technology, 2022–2035

 9.2.3 Lyme Disease Testing Market Size & Forecast, By Sample Type, 2022–2035

 9.2.4 Lyme Disease Testing Market Size & Forecast, By Patient Type, 2022–2035

 9.2.5 Lyme Disease Testing Market Size & Forecast, By End Use, 2022–2035

 9.2.6 Lyme Disease Testing Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Lyme Disease Testing Market Size & Forecast, By Technology, 2022–2035

 9.3.3 Lyme Disease Testing Market Size & Forecast, By Sample Type, 2022–2035

 9.3.4 Lyme Disease Testing Market Size & Forecast, By Patient Type, 2022–2035

 9.3.5 Lyme Disease Testing Market Size & Forecast, By End Use, 2022–2035

 9.3.6 Lyme Disease Testing Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Lyme Disease Testing Market Size & Forecast, By Technology, 2022–2035

 9.4.3 Lyme Disease Testing Market Size & Forecast, By Sample Type, 2022–2035

 9.4.4 Lyme Disease Testing Market Size & Forecast, By Patient Type, 2022–2035

 9.4.5 Lyme Disease Testing Market Size & Forecast, By End Use, 2022–2035

 9.4.6 Lyme Disease Testing Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Lyme Disease Testing Market Size & Forecast, By Technology, 2022–2035

 9.5.3 Lyme Disease Testing Market Size & Forecast, By Sample Type, 2022–2035

 9.5.4 Lyme Disease Testing Market Size & Forecast, By Patient Type, 2022–2035

 9.5.5 Lyme Disease Testing Market Size & Forecast, By End Use, 2022–2035

 9.5.6 Lyme Disease Testing Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Lyme Disease Testing Market Size & Forecast, By Technology, 2022–2035

 9.6.3 Lyme Disease Testing Market Size & Forecast, By Sample Type, 2022–2035

 9.6.4 Lyme Disease Testing Market Size & Forecast, By Patient Type, 2022–2035

 9.6.5 Lyme Disease Testing Market Size & Forecast, By End Use, 2022–2035

 9.6.6 Lyme Disease Testing Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Quest Diagnostics Incorporated.

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

10.6.2 Laboratory Corporation of America (Labcorp)

10.6.3 Thermo Fisher Scientific Inc.

10.6.4 Bio-Rad Laboratories Inc.

10.6.5 DiaSorin SpA

10.6.6 Siemens Healthineers AG

10.6.7 Roche Diagnostics GmbH

10.6.8 Immunetics Inc.

10.6.9 EUROIMMUN AG

10.6.10 IDEXX Laboratories Inc.

10.6.11 Abbott Laboratories

10.6.12 Becton Dickinson and Company

10.6.13 Meridian Bioscience Inc.

10.6.14 Biopanda Reagents Ltd.

10.6.15 Zeus Scientific Inc.

10.6.16 Stony Brook Medicine Laboratory

10.6.17 Virotech Diagnostics GmbH

10.6.18 Binding Site Group Ltd.

10.6.19 INOVA Diagnostics Inc.

10.6.20 Qiagen NV.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures